BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pennell DJ, Udelson JE, Arai AE, Bozkurt B, Cohen AR, Galanello R, Hoffman TM, Kiernan MS, Lerakis S, Piga A. Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association. Circulation. 2013;128:281-308. [PMID: 23775258 DOI: 10.1161/cir.0b013e31829b2be6] [Cited by in Crossref: 187] [Cited by in F6Publishing: 71] [Article Influence: 20.8] [Reference Citation Analysis]
Number Citing Articles
1 Latus H, Voges I. Quantitative Tissue Characterization in Pediatric Cardiology. Curr Cardiovasc Imaging Rep 2017;10. [DOI: 10.1007/s12410-017-9405-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Lioudaki E, Whyte M. Acute cardiac decompensation in a patient with beta-thalassemia and diabetes mellitus following cessation of chelation therapy. Clin Case Rep 2016;4:992-6. [PMID: 27761254 DOI: 10.1002/ccr3.686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Gabr H, El Ghamrawy MK, Almaeen AH, Abdelhafiz AS, Hassan AOS, El Sissy MH. CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation. Stem Cell Res Ther 2020;11:390. [PMID: 32912325 DOI: 10.1186/s13287-020-01876-4] [Reference Citation Analysis]
4 Viprakasit V, Rodmai S, Srichairatanakool S. Deferiprone for transfusional iron overload and its roles in developing countries. Expert Opinion on Orphan Drugs 2014;2:189-200. [DOI: 10.1517/21678707.2014.885388] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Peterzan MA, Rider OJ, Anderson LJ. The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure. Card Fail Rev 2016;2:115-22. [PMID: 28785465 DOI: 10.15420/cfr.2016.2.2.115] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
6 Silvilairat S, Charoenkwan P, Saekho S, Tantiworawit A, Srichairatanakool S. Early detection of ventricular dysfunction by tissue Doppler echocardiography related to cardiac iron overload in patients with thalassemia. Int J Cardiovasc Imaging 2021;37:91-8. [PMID: 32728990 DOI: 10.1007/s10554-020-01949-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Spasiano A, Meloni A, Costantini S, Quaia E, Cademartiri F, Cinque P, Pepe A, Ricchi P. Setting for "Normal" Serum Ferritin Levels in Patients with Transfusion-Dependent Thalassemia: Our Current Strategy. J Clin Med 2021;10:5985. [PMID: 34945281 DOI: 10.3390/jcm10245985] [Reference Citation Analysis]
8 Sung HK, Song E, Jahng JWS, Pantopoulos K, Sweeney G. Iron induces insulin resistance in cardiomyocytes via regulation of oxidative stress. Sci Rep 2019;9:4668. [PMID: 30874600 DOI: 10.1038/s41598-019-41111-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
9 Russo V, Melillo E, Papa AA, Rago A, Chamberland C, Nigro G. Arrhythmias and Sudden Cardiac Death in Beta-Thalassemia Major Patients: Noninvasive Diagnostic Tools and Early Markers. Cardiol Res Pract 2019;2019:9319832. [PMID: 31885907 DOI: 10.1155/2019/9319832] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Cheung YF, So EK, Hwang GY, Chan GC, Ha SY. Left and Right Atrial Function and Remodeling in Beta-Thalassaemia Major. Pediatr Cardiol 2019;40:1001-8. [PMID: 30972436 DOI: 10.1007/s00246-019-02105-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Cilsal E. Immobile Tricuspid Valve: Incidental Finding in a Case of Terminal Cardiomyopathy Due to Thalassemia Major. Arq Bras Cardiol 2019;113:438-43. [PMID: 31621785 DOI: 10.5935/abc.20190195] [Reference Citation Analysis]
12 Lopes ICC, Schütze M, Bolina MB, de Oliveira Sobrinho TÂ, Ramos LFM, Diniz RLFC, Fernandes JL, Siqueira MHA. Comparison of automated and manual protocols for magnetic resonance imaging assessment of liver iron concentration. Radiol Bras 2020;53:148-54. [PMID: 32587421 DOI: 10.1590/0100-3984.2019.0029] [Reference Citation Analysis]
13 Heiss R, Wiesmueller M, Treutlein C, Seuss H, Uder M, May M, Wuest W. Cardiac T2 star mapping: standardized inline analysis of long and short axis at three identical 1.5 T MRI scanners. Int J Cardiovasc Imaging 2019;35:695-702. [PMID: 30465128 DOI: 10.1007/s10554-018-1503-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
14 Westwood MA, Pennell DJ. Reducing mortality by myocardial T2* cardiovascular magnetic resonance at national level. Eur Heart J 2021:ehab814. [PMID: 34907427 DOI: 10.1093/eurheartj/ehab814] [Reference Citation Analysis]
15 Huang F, Yang R, Xiao Z, Xie Y, Lin X, Zhu P, Zhou P, Lu J, Zheng S. Targeting Ferroptosis to Treat Cardiovascular Diseases: A New Continent to Be Explored. Front Cell Dev Biol 2021;9:737971. [PMID: 34527678 DOI: 10.3389/fcell.2021.737971] [Reference Citation Analysis]
16 Das SK, Zhabyeyev P, Basu R, Patel VB, Dyck JRB, Kassiri Z, Oudit GY. Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy. Biosci Rep 2018;38:BSR20171302. [PMID: 29208771 DOI: 10.1042/BSR20171302] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
17 Murillo-Ortiz B, Ramírez Emiliano J, Hernández Vázquez WI, Martínez-Garza S, Solorio-Meza S, Albarrán-Tamayo F, Ramos-Rodríguez E, Benítez-Bribiesca L. Impact of Oxidative Stress in Premature Aging and Iron Overload in Hemodialysis Patients. Oxid Med Cell Longev 2016;2016:1578235. [PMID: 27800120 DOI: 10.1155/2016/1578235] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
18 Pepe A, Pistoia L, Gamberini MR, Cuccia L, Lisi R, Cecinati V, Maggio A, Sorrentino F, Filosa A, Rosso R, Messina G, Missere M, Righi R, Renne S, Vallone A, Dalmiani S, Positano V, Midiri M, Meloni A. National networking in rare diseases and reduction of cardiac burden in thalassemia major. Eur Heart J 2021:ehab851. [PMID: 34907420 DOI: 10.1093/eurheartj/ehab851] [Reference Citation Analysis]
19 Mavrogeni S, Kolovou G, Bigalke B, Rigopoulos A, Noutsias M, Adamopoulos S. Transplantation in patients with iron overload: is there a place for magnetic resonance imaging? : Transplantation in iron overload. Heart Fail Rev 2018;23:173-80. [PMID: 29359261 DOI: 10.1007/s10741-018-9670-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Sascău R, Anghel L, Clement A, Bostan M, Radu R, Stătescu C. The Importance of Multimodality Imaging in the Diagnosis and Management of Patients with Infiltrative Cardiomyopathies: An Update. Diagnostics (Basel) 2021;11:256. [PMID: 33562254 DOI: 10.3390/diagnostics11020256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Das SK, Wang W, Zhabyeyev P, Basu R, McLean B, Fan D, Parajuli N, DesAulniers J, Patel VB, Hajjar RJ, Dyck JR, Kassiri Z, Oudit GY. Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy. Sci Rep 2015;5:18132. [PMID: 26638758 DOI: 10.1038/srep18132] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 7.7] [Reference Citation Analysis]
22 Puntmann VO, Valbuena S, Hinojar R, Petersen SE, Greenwood JP, Kramer CM, Kwong RY, McCann GP, Berry C, Nagel E; SCMR Clinical Trial Writing Group. Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification. J Cardiovasc Magn Reson 2018;20:67. [PMID: 30231886 DOI: 10.1186/s12968-018-0484-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
23 Ehsan L, Rashid M, Alvi N, Awais K, Nadeem O, Asghar A, Sajjad F, Fatima M, Qidwai A, Hussain S, Hasan E, Brown N, Altaf S, Hasan B, Kirmani S. Clinical utility of endocrine markers predicting myocardial siderosis in transfusion dependent thalassemia major. Pediatr Blood Cancer 2018;65:e27285. [PMID: 29893484 DOI: 10.1002/pbc.27285] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
24 Coates TD. Iron overload in transfusion-dependent patients. Hematology Am Soc Hematol Educ Program 2019;2019:337-44. [PMID: 31808901 DOI: 10.1182/hematology.2019000036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
25 Esposito A, Gallone G, Palmisano A, Marchitelli L, Catapano F, Francone M. The current landscape of imaging recommendations in cardiovascular clinical guidelines: toward an imaging-guided precision medicine. Radiol Med 2020;125:1013-23. [PMID: 32964326 DOI: 10.1007/s11547-020-01286-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
26 Ditaranto R, Caponetti AG, Ferrara V, Parisi V, Minnucci M, Chiti C, Baldassarre R, Di Nicola F, Bonetti S, Hasan T, Potena L, Galiè N, Ragni L, Biagini E. Pediatric Restrictive Cardiomyopathies. Front Pediatr 2022;9:745365. [DOI: 10.3389/fped.2021.745365] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Kumar A, Bagur R. Cardiac magnetic resonance in clinical cardiology. World J Cardiol 2015; 7(1): 6-9 [PMID: 25632313 DOI: 10.4330/wjc.v7.i1.6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
28 Wood JC. Use of magnetic resonance imaging to monitor iron overload. Hematol Oncol Clin North Am 2014;28:747-64, vii. [PMID: 25064711 DOI: 10.1016/j.hoc.2014.04.002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 8.6] [Reference Citation Analysis]
29 Oduor H, Minniti CP, Brofferio A, Gharib AM, Abd-Elmoniem KZ, Hsieh MM, Tisdale JF, Fitzhugh CD. Severe cardiac iron toxicity in two adults with sickle cell disease. Transfusion 2017;57:700-4. [PMID: 28019032 DOI: 10.1111/trf.13961] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
30 Taher AT, Saliba AN. Iron overload in thalassemia: different organs at different rates. Hematology Am Soc Hematol Educ Program. 2017;2017:265-271. [PMID: 29222265 DOI: 10.1182/asheducation-2017.1.265] [Cited by in Crossref: 61] [Cited by in F6Publishing: 45] [Article Influence: 15.3] [Reference Citation Analysis]
31 Ahmed RA, Salih AF, Omer SH, Rahman HS, Rasool LK. Early Detection of Iron Overload Cardiomyopathy in Transfusion Dependent Thalassemia Patients in Sulaimaniyah City, Iraq. Ther Clin Risk Manag 2022;18:259-71. [PMID: 35345642 DOI: 10.2147/TCRM.S354574] [Reference Citation Analysis]
32 Siri-Angkul N, Xie LH, Chattipakorn SC, Chattipakorn N. Cellular Electrophysiology of Iron-Overloaded Cardiomyocytes. Front Physiol 2018;9:1615. [PMID: 30498456 DOI: 10.3389/fphys.2018.01615] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
33 Torlasco C, Cassinerio E, Roghi A, Faini A, Capecchi M, Abdel-Gadir A, Giannattasio C, Parati G, Moon JC, Cappellini MD, Pedrotti P. Role of T1 mapping as a complementary tool to T2* for non-invasive cardiac iron overload assessment. PLoS One 2018;13:e0192890. [PMID: 29466447 DOI: 10.1371/journal.pone.0192890] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
34 Vlachou M, Kamperidis V, Vlachaki E, Tziatzios G, Pantelidou D, Boutou A, Apostolou C, Papadopoulou D, Giannakoulas G, Karvounis H. Left Atrial Strain Identifies Increased Atrial Ectopy in Patients with Beta-Thalassemia Major. Diagnostics (Basel) 2020;11:E1. [PMID: 33375056 DOI: 10.3390/diagnostics11010001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Alam MH, Auger D, Smith GC, He T, Vassiliou V, Baksi AJ, Wage R, Drivas P, Feng Y, Firmin DN, Pennell DJ. T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis. J Cardiovasc Magn Reson 2015;17:102. [PMID: 26602203 DOI: 10.1186/s12968-015-0207-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
36 Baksi AJ, Pennell DJ. Randomized controlled trials of iron chelators for the treatment of cardiac siderosis in thalassaemia major. Front Pharmacol 2014;5:217. [PMID: 25295007 DOI: 10.3389/fphar.2014.00217] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
37 Pistoia L, Meloni A, Ricchi P, Filosa A, Lisi R, Maggio A, Rosso R, Messina G, Iacono ND, Cuccia L, Campisi S, Missere M, Midiri M, Vallone A, Renne S, Schicchi N, Righi R, Mangione M, Positano V, Pepe A. Genotypic groups as risk factors for cardiac magnetic resonance abnormalities and complications in thalassemia major: a large, multicentre study. Blood Transfus 2021;19:168-76. [PMID: 33000750 DOI: 10.2450/2020.0023-20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Saliba AN, Harb AR, Taher AT. Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions. J Blood Med 2015;6:197-209. [PMID: 26124688 DOI: 10.2147/JBM.S72463] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
39 Li J, Lin Y, Li X, Zhang J. Economic Evaluation of Chelation Regimens for β-Thalassemia Major: a Systematic Review. Mediterr J Hematol Infect Dis 2019;11:e2019036. [PMID: 31308912 DOI: 10.4084/MJHID.2019.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
40 Casale M, Meloni A, Filosa A, Cuccia L, Caruso V, Palazzi G, Rita Gamberini M, Pitrolo L, Caterina Putti M, Giuseppe D’ascola D, Casini T, Quarta A, Maggio A, Giovanna Neri M, Positano V, Salvatori C, Toia P, Valeri G, Midiri M, Pepe A. Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major: A Multicenter Study. Circ: Cardiovascular Imaging 2015;8. [DOI: 10.1161/circimaging.115.003230] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
41 Das SK, Patel VB, Basu R, Wang W, DesAulniers J, Kassiri Z, Oudit GY. Females Are Protected From Iron-Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress. J Am Heart Assoc 2017;6:e003456. [PMID: 28115312 DOI: 10.1161/JAHA.116.003456] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
42 Khaled A, Ezzat DA, Salem HA, Seif HM, Rabee H. Effective method of evaluating myocardial iron concentration in pediatric patients with thalassemia major. J Blood Med 2019;10:227-33. [PMID: 31372080 DOI: 10.2147/JBM.S204848] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Pasteur-Rousseau A, Odouard S, Souibri K, Sebag FA, Deux JF, Damy T. [Cardiac imaging in infiltrative cardiomyopathies. What cardiovascular imaging modalities to propose in hypertrophic cardiomyopathies ?]. Ann Cardiol Angeiol (Paris) 2022:S0003-3928(22)00039-7. [PMID: 35184821 DOI: 10.1016/j.ancard.2022.01.001] [Reference Citation Analysis]
44 Pinto VM, Forni GL. Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series. Int J Mol Sci 2020;21:E8771. [PMID: 33233561 DOI: 10.3390/ijms21228771] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
45 Shah FT, Porter JB, Sadasivam N, Kaya B, Moon JC, Velangi M, Ako E, Pancham S. Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias. Br J Haematol 2021. [PMID: 34617272 DOI: 10.1111/bjh.17839] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Ragab SM, Fathy WM, El-Aziz WF, Helal RT. The Diagnostic Value of Pulsed Wave Tissue Doppler Imaging in Asymptomatic Beta- Thalassemia Major Children and Young Adults; Relation to Chemical Biomarkers of Left Ventricular Function and Iron Overload. Mediterr J Hematol Infect Dis 2015;7:e2015051. [PMID: 26401240 DOI: 10.4084/MJHID.2015.051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
47 Lipshultz SE, Law YM, Asante-Korang A, Austin ED, Dipchand AI, Everitt MD, Hsu DT, Lin KY, Price JF, Wilkinson JD, Colan SD. Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association. Circulation 2019;140:e9-e68. [PMID: 31132865 DOI: 10.1161/CIR.0000000000000682] [Cited by in Crossref: 58] [Cited by in F6Publishing: 26] [Article Influence: 19.3] [Reference Citation Analysis]
48 Origa R, Cinus M, Pilia MP, Gianesin B, Zappu A, Orecchia V, Clemente MG, Pitturru C, Denotti AR, Corongiu F, Piras S, Barella S. Safety and Efficacy of the New Combination Iron Chelation Regimens in Patients with Transfusion-Dependent Thalassemia and Severe Iron Overload. J Clin Med 2022;11:2010. [PMID: 35407617 DOI: 10.3390/jcm11072010] [Reference Citation Analysis]
49 Asadian S, Hosseini L, Rezaeian N. The Importance of Functional and Feature-Tracking Cardiac MRI Parameters in Prediction of Adverse Cardiac Events and Cardiac Mortality in Thalassemia Patients. Acad Radiol 2022;29 Suppl 4:S91-9. [PMID: 35131148 DOI: 10.1016/j.acra.2022.01.001] [Reference Citation Analysis]
50 Kamperidis V, Vlachou M, Pappa Z, Pantelidou D, Karamitsos T, Papadopoulou D, Kartas A, Boutou A, Ventoulis I, Vlachaki E, Giannakoulas G, Karvounis H. Prediction of long-term survival in patients with transfusion-dependent hemoglobinopathies: Insights from cardiac imaging and ferritin. Hellenic J Cardiol 2021;62:429-38. [PMID: 33524617 DOI: 10.1016/j.hjc.2021.01.010] [Reference Citation Analysis]
51 Camargo GC, Rothstein T, Junqueira FP, Fernandes E, Greiser A, Strecker R, Pessoa V, Lima RS, Gottlieb I. Comparison of myocardial T1 and T2 values in 3 T with T2* in 1.5 T in patients with iron overload and controls. Int J Hematol 2016;103:530-6. [PMID: 26872908 DOI: 10.1007/s12185-016-1950-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
52 Golforoush P, Schneider MD. Intensive care for human hearts in pluripotent stem cell models. NPJ Regen Med 2020;5:4. [PMID: 32194989 DOI: 10.1038/s41536-020-0090-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
53 Aronow WS. Management of cardiac hemochromatosis. Arch Med Sci 2018;14:560-8. [PMID: 29765443 DOI: 10.5114/aoms.2017.68729] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
54 Wood JC. Estimating tissue iron burden: current status and future prospects. Br J Haematol 2015;170:15-28. [PMID: 25765344 DOI: 10.1111/bjh.13374] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 10.1] [Reference Citation Analysis]
55 Radenkovic D, Weingärtner S, Ricketts L, Moon JC, Captur G. T1 mapping in cardiac MRI. Heart Fail Rev 2017;22:415-30. [PMID: 28623475 DOI: 10.1007/s10741-017-9627-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 14.0] [Reference Citation Analysis]
56 Khaled A, Salem HA, Ezzat DA, Seif HM, Rabee H. A randomized controlled trial evaluating the effects of amlodipine on myocardial iron deposition in pediatric patients with thalassemia major. Drug Des Devel Ther 2019;13:2427-36. [PMID: 31413542 DOI: 10.2147/DDDT.S211630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Ambarwati L, Rahayuningsih SE, Setiabudiawan B. Association between vitamin D levels and left ventricular function and NT-proBNP levels among thalassemia major children with iron overload. Ann Pediatr Cardiol 2016;9:126-31. [PMID: 27212846 DOI: 10.4103/0974-2069.181495] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
58 Ibrahim MH, Azab AA, Kamal NM, Salama MA, Ebrahim SA, Shahin AM, El-Sadek AE, Abdulghany WE, Sherief LM, Abdallah EA. Early detection of myocardial dysfunction in poorly treated pediatric thalassemia children and adolescents: Two Saudi centers experience. Ann Med Surg (Lond) 2016;9:6-11. [PMID: 27330742 DOI: 10.1016/j.amsu.2016.05.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
59 Longo F, Corrieri P, Origa R, Barella S, Sanna PMG, Bitti PP, Zuccarelli A, Commendatore FV, Vitucci A, Quarta A, Lisi R, Cappellini MD, Massei F, Forni GL, Piga A. Changing patterns of thalassaemia in Italy: a WebThal perspective. Blood Transfus 2021;19:261-8. [PMID: 33196416 DOI: 10.2450/2020.0143-20] [Reference Citation Analysis]
60 Pennell DJ, Porter JB, Piga A, Lai YR, El-Beshlawy A, Elalfy M, Yesilipek A, Kilinç Y, Habr D, Musallam KM, Shen J, Aydinok Y; CORDELIA study investigators. Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine. Am J Hematol 2015;90:91-6. [PMID: 25345697 DOI: 10.1002/ajh.23876] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
61 Dev S, Babitt JL. Overview of iron metabolism in health and disease. Hemodial Int 2017;21 Suppl 1:S6-S20. [PMID: 28296010 DOI: 10.1111/hdi.12542] [Cited by in Crossref: 103] [Cited by in F6Publishing: 95] [Article Influence: 20.6] [Reference Citation Analysis]
62 Lee JX, Chieng WK, Lau SCD, Tan CE. COVID-19 and Hemoglobinopathies: A Systematic Review of Clinical Presentations, Investigations, and Outcomes. Front Med (Lausanne) 2021;8:757510. [PMID: 34722593 DOI: 10.3389/fmed.2021.757510] [Reference Citation Analysis]
63 Alam MH, He T, Auger D, Smith GC, Drivas P, Wage R, Izgi C, Symmonds K, Greiser A, Spottiswoode BS, Anderson L, Firmin D, Pennell DJ. Validation of T2* in-line analysis for tissue iron quantification at 1.5 T. J Cardiovasc Magn Reson 2016;18:23. [PMID: 27121114 DOI: 10.1186/s12968-016-0243-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
64 Mancardi D, Mezzanotte M, Arrigo E, Barinotti A, Roetto A. Iron Overload, Oxidative Stress, and Ferroptosis in the Failing Heart and Liver. Antioxidants (Basel) 2021;10:1864. [PMID: 34942967 DOI: 10.3390/antiox10121864] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Meloni A, Martini N, Positano V, De Luca A, Pistoia L, Sbragi S, Spasiano A, Casini T, Bitti PP, Allò M, Sanna PMG, De Caterina R, Sinagra G, Pepe A. Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications. J Cardiovasc Magn Reson 2021;23:70. [PMID: 34120634 DOI: 10.1186/s12968-021-00765-w] [Reference Citation Analysis]
66 Kamal S, Abdelhakam S, Ghoraba D, Mohsen MA, Salam AA, Hassan H, Nabeigh L. The Course of Hepatitis C Infection and Response to Anti-viral Therapy in Patients with Thalassemia major and Hepatitis C Infection: A Longitudinal, Prospective Study. Mediterr J Hematol Infect Dis 2019;11:e2019060. [PMID: 31700585 DOI: 10.4084/MJHID.2019.060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
67 Zhong Z, Liu J, Zhang Q, Zhong W, Li B, Li C, Liu Z, Yang M, Zhao P. Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China. Med Sci Monit 2018;24:4154-61. [PMID: 29910459 DOI: 10.12659/MSM.907400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
68 Makmettakul S, Tantiworawit A, Phrommintikul A, Piriyakhuntorn P, Rattanathammethee T, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E, Norasetthada L, Fanhchaksai K, Charoenkwan P, Lekawanvijit S. Cardiorenal syndrome in thalassemia patients. BMC Nephrol 2020;21:325. [PMID: 32746879 DOI: 10.1186/s12882-020-01990-8] [Reference Citation Analysis]
69 Coates TD, Wood JC. How we manage iron overload in sickle cell patients. Br J Haematol 2017;177:703-16. [PMID: 28295188 DOI: 10.1111/bjh.14575] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
70 Patsourakos D, Gatzoulis KA, Aggeli C, Delicou S, Dimitroglou Y, Xydaki K, Toutouzas K, Androulakis A, Tousoulis D. Twelve-lead and signal-averaged electrocardiographic parameters among beta-thalassemia major patients. J Arrhythm 2020;36:920-8. [PMID: 33024470 DOI: 10.1002/joa3.12412] [Reference Citation Analysis]
71 Lima da Cruz GJ, Velasco C, Lavin B, Jaubert O, Botnar RM, Prieto C. Myocardial T1, T2, T2*, and fat fraction quantification via low-rank motion-corrected cardiac MR fingerprinting. Magn Reson Med 2022. [PMID: 35081260 DOI: 10.1002/mrm.29171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Ordovas KG, Baldassarre LA, Bucciarelli-Ducci C, Carr J, Fernandes JL, Ferreira VM, Frank L, Mavrogeni S, Ntusi N, Ostenfeld E, Parwani P, Pepe A, Raman SV, Sakuma H, Schulz-Menger J, Sierra-Galan LM, Valente AM, Srichai MB. Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR). J Cardiovasc Magn Reson 2021;23:52. [PMID: 33966639 DOI: 10.1186/s12968-021-00746-z] [Reference Citation Analysis]
73 Saadatifar H, Niayeshfar A, Mard-Soltani M, Bahrampour E, Khalili S, Alinezhad Dezfuli D, Pouriamehr S. The correlation of cardiac biomarkers and myocardial iron overload based on T2* MRI in major beta-thalassemia. Int J Cardiovasc Imaging 2021. [PMID: 34727252 DOI: 10.1007/s10554-021-02458-y] [Reference Citation Analysis]
74 Alis D, Asmakutlu O, Topel C, Sahin AA, Karaarslan E. Association between left ventricular strain and cardiac iron load in beta-thalassaemia major: a cardiac magnetic resonance study. Acta Cardiol 2022;77:71-80. [PMID: 33685353 DOI: 10.1080/00015385.2021.1887585] [Reference Citation Analysis]
75 Botta A, Forest A, Daneault C, Pantopoulos K, Tantiworawit A, Phrommintikul A, Chattipakorn S, Chattipakorn N, Des Rosiers C, Sweeney G. Identification of Circulating Endocan-1 and Ether Phospholipids as Biomarkers for Complications in Thalassemia Patients. Metabolites 2021;11:70. [PMID: 33530524 DOI: 10.3390/metabo11020070] [Reference Citation Analysis]
76 Ojha V, Ganga KP, Seth T, Roy A, Naik N, Jagia P, Gulati GS, Kumar S, Sharma S. Role of CMR feature-tracking derived left ventricular strain in predicting myocardial iron overload and assessing myocardial contractile dysfunction in patients with thalassemia major. Eur Radiol 2021;31:6184-92. [PMID: 33721061 DOI: 10.1007/s00330-020-07599-7] [Reference Citation Analysis]
77 Kalisz K, Rajiah P. Impact of cardiac magnetic resonance imaging in non-ischemic cardiomyopathies. World J Cardiol 2016; 8(2): 132-145 [PMID: 26981210 DOI: 10.4330/wjc.v8.i2.132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
78 Kattamis A, Kwiatkowski JL, Aydinok Y. Thalassaemia. The Lancet 2022;399:2310-24. [DOI: 10.1016/s0140-6736(22)00536-0] [Reference Citation Analysis]
79 Fianza PI, Rahmawati A, Afifah S, Praptama S, Ghozali M, Sihite TA, Setiabudi D, Syamsunarno MRAA, Fucharoen S, Panigoro R. Correlation between Serum Fatty Acid Binding Protein 4 (FABP4) Levels and Cardiac Function in Patients with Thalassemia Major. Dis Markers 2021;2021:5130628. [PMID: 34987673 DOI: 10.1155/2021/5130628] [Reference Citation Analysis]
80 Chinprateep B, Ratanasit N, Kaolawanich Y, Karaketklang K, Saiviroonporn P, Viprakasit V, Krittayaphong R. Prevalence of left ventricular diastolic dysfunction by cardiac magnetic resonance imaging in thalassemia major patients with normal left ventricular systolic function. BMC Cardiovasc Disord 2019;19:245. [PMID: 31694552 DOI: 10.1186/s12872-019-1235-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
81 Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, Mascherbauer J, Nezafat R, Salerno M, Schelbert EB, Taylor AJ, Thompson R, Ugander M, van Heeswijk RB, Friedrich MG. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017;19:75. [PMID: 28992817 DOI: 10.1186/s12968-017-0389-8] [Cited by in Crossref: 509] [Cited by in F6Publishing: 440] [Article Influence: 101.8] [Reference Citation Analysis]
82 Brown GC, Cowin GJ, Galloway GJ. A USPIO doped gel phantom for R2* relaxometry. MAGMA 2017;30:15-27. [PMID: 27435747 DOI: 10.1007/s10334-016-0576-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
83 Menacho K, Ramirez S, Segura P, Nordin S, Abdel-Gadir A, Illatopa V, Bhuva A, Benedetti G, Boubertakh R, Abad P, Rodriguez B, Medina F, Treibel T, Westwood M, Fernandes J, Walker JM, Litt H, Moon JC. INCA (Peru) Study: Impact of Non-Invasive Cardiac Magnetic Resonance Assessment in the Developing World. J Am Heart Assoc 2018;7:e008981. [PMID: 30371164 DOI: 10.1161/JAHA.118.008981] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
84 Ricchi P, Meloni A, Grigoratos C, Toia P, Fina P, Pistoia L, Costantini S, Borsellino Z, Lisi R, Rocca M, Preziosi P, Midiri M, Pepe A. Prevalence of extramedullary hematopoiesis, renal cysts, splenic and hepatic lesions, and vertebral hemangiomas among thalassemic patients: a retrospective study from the Myocardial Iron Overload in Thalassemia (MIOT) network. Ann Hematol 2019;98:1333-9. [PMID: 30891614 DOI: 10.1007/s00277-019-03659-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
85 Jackson LH, Vlachodimitropoulou E, Shangaris P, Roberts TA, Ryan TM, Campbell-Washburn AE, David AL, Porter JB, Lythgoe MF, Stuckey DJ. Non-invasive MRI biomarkers for the early assessment of iron overload in a humanized mouse model of β-thalassemia. Sci Rep 2017;7:43439. [PMID: 28240317 DOI: 10.1038/srep43439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
86 Vela D. Keeping heart homeostasis in check through the balance of iron metabolism. Acta Physiol (Oxf) 2020;228:e13324. [PMID: 31162883 DOI: 10.1111/apha.13324] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
87 Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER, Vogel-Claussen J, Turkbey EB, Williams R, Plein S, Tee M, Eng J, Bluemke DA. Normal values for cardiovascular magnetic resonance in adults and children. J Cardiovasc Magn Reson 2015;17:29. [PMID: 25928314 DOI: 10.1186/s12968-015-0111-7] [Cited by in Crossref: 392] [Cited by in F6Publishing: 333] [Article Influence: 56.0] [Reference Citation Analysis]
88 Kawel-Boehm N, Hetzel SJ, Ambale-Venkatesh B, Captur G, Francois CJ, Jerosch-Herold M, Salerno M, Teague SD, Valsangiacomo-Buechel E, van der Geest RJ, Bluemke DA. Reference ranges ("normal values") for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update. J Cardiovasc Magn Reson 2020;22:87. [PMID: 33308262 DOI: 10.1186/s12968-020-00683-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
89 Li J, Wang P, Li X, Wang Q, Zhang J, Lin Y. Cost-Utility Analysis of four Chelation Regimens for β-thalassemia Major: a Chinese Perspective. Mediterr J Hematol Infect Dis 2020;12:e2020029. [PMID: 32395218 DOI: 10.4084/MJHID.2020.029] [Reference Citation Analysis]
90 Kaya B. Overview of Chelation Recommendations for Thalassaemia and Sickle Cell Disease. Thalassemia Reports 2014;4:4860. [DOI: 10.4081/thal.2014.4860] [Reference Citation Analysis]
91 Alam MH, Auger D, McGill LA, Smith GC, He T, Izgi C, Baksi AJ, Wage R, Drivas P, Firmin DN, Pennell DJ. Comparison of 3 T and 1.5 T for T2* magnetic resonance of tissue iron. J Cardiovasc Magn Reson 2016;18:40. [PMID: 27391316 DOI: 10.1186/s12968-016-0259-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
92 Nazarova EE, Tereshchenko GV, Kupriyanov DA, Smetanina NS, Novichkova GA. Free-breathing T2* mapping for MR myocardial iron assessment at 3 T. Eur Radiol Exp 2020;4:25. [PMID: 32303909 DOI: 10.1186/s41747-020-00156-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Akyuz E, Doganyigit Z, Eroglu E, Moscovicz F, Merelli A, Lazarowski A, Auzmendi J. Myocardial Iron Overload in an Experimental Model of Sudden Unexpected Death in Epilepsy. Front Neurol 2021;12:609236. [PMID: 33643194 DOI: 10.3389/fneur.2021.609236] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
94 Zhabyeyev P, Das SK, Basu R, Shen M, Patel VB, Kassiri Z, Oudit GY. TIMP3 deficiency exacerbates iron overload-mediated cardiomyopathy and liver disease. Am J Physiol Heart Circ Physiol 2018;314:H978-90. [PMID: 29373036 DOI: 10.1152/ajpheart.00597.2017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
95 Ma W, Jia L, Xiong Q, Du H. Iron Overload Protects from Obesity by Ferroptosis. Foods 2021;10:1787. [PMID: 34441564 DOI: 10.3390/foods10081787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
96 Samuel PP, Case DA. Atomistic Simulations of Heme Dissociation Pathways in Human Methemoglobins Reveal Hidden Intermediates. Biochemistry 2020;59:4093-107. [PMID: 32945658 DOI: 10.1021/acs.biochem.0c00607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Kontoghiorghes GJ, Kleanthous M, Kontoghiorghe CN. The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia. Mediterr J Hematol Infect Dis 2020;12:e2020011. [PMID: 31934321 DOI: 10.4084/MJHID.2020.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
98 Edmonston D, Morris JD, Middleton JP. Working Toward an Improved Understanding of Chronic Cardiorenal Syndrome Type 4. Adv Chronic Kidney Dis 2018;25:454-67. [PMID: 30309463 DOI: 10.1053/j.ackd.2018.08.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Barbero U, Ajassa M, Gaglioti CM, Piga A, Ferrero GB, Longo F. The Influence of Cardiovascular Risk Factors and Hypogonadism on Cardiac Outcomes in an Aging Population of Beta-Thalassemia Patients. J Cardiovasc Dev Dis 2021;9:3. [PMID: 35050213 DOI: 10.3390/jcdd9010003] [Reference Citation Analysis]
100 Halliday BP, Pennell DJ. Cardiovascular Magnetic Resonance to Guide and Monitor the Myocardial Response to Treatment. Circ Cardiovasc Imaging 2019;12:e010045. [PMID: 31826674 DOI: 10.1161/CIRCIMAGING.119.010045] [Reference Citation Analysis]